SLU-PP-332 (250mcg Capsule) Dosage Protocol Contents Quickstart Highlights SLU-PP-332 (also referenced in primary literature as SLU-PP-332) is a synthetic small-molecule pan-agonist of the estrogen-related receptors (ERR, ERR, ERR)
All of the test subjects included in the study were randomly assigned to 1 of 10 different experimental treatment groups
Our protocols have always prioritized safety and efficacy, and we will continue to source our peptides from only the most reputable, licensed compounding pharmacies
So Should We Drink Beet Juice, or Not
Over the years peptides have been evolved as promising therapeutic agents in the treatment of cancer, diabetes, and cardiovascular diseases, and application of peptides in a variety of other therapeutic areas is growing rapidly
The biggest problem with this approach is the lack of support for anything but traditionally encapsulated NMN and NR powders